These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15946747)

  • 21. Signaling mechanisms of GPCR ligands.
    Strange PG
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):196-202. PubMed ID: 18283607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions.
    Szidonya L; Cserzo M; Hunyady L
    J Endocrinol; 2008 Mar; 196(3):435-53. PubMed ID: 18310440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methods to monitor the quaternary structure of G protein-coupled receptors.
    Milligan G; Bouvier M
    FEBS J; 2005 Jun; 272(12):2914-25. PubMed ID: 15955052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ligand-independent translocation assay: an enabling technology for screening orphan G protein-coupled receptors by arrestin recruitment.
    Oakley RH; Hudson CC; Sjaastad MD; Loomis CR
    Methods Enzymol; 2006; 414():50-63. PubMed ID: 17110186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
    Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE
    Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanding GPCR homology model binding sites via a balloon potential: A molecular dynamics refinement approach.
    Kimura SR; Tebben AJ; Langley DR
    Proteins; 2008 Jun; 71(4):1919-29. PubMed ID: 18175323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of automated in silico ligand docking of amino acid ligands to Family C G-protein coupled receptors.
    Wang M; Hampson DR
    Bioorg Med Chem; 2006 Mar; 14(6):2032-9. PubMed ID: 16297630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G-protein-coupled receptor heterodimerization: assay technologies to clinical significance.
    Kent T; McAlpine C; Sabetnia S; Presland J
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):580-9. PubMed ID: 17786857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G-Protein-coupled receptor-protein interactions: basis for new concepts on receptor structure and function.
    Tilakaratne N; Sexton PM
    Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):979-87. PubMed ID: 16405456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
    Radestock S; Weil T; Renner S
    J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid-state NMR evidence for a protonation switch in the binding pocket of the H1 receptor upon binding of the agonist histamine.
    Ratnala VR; Kiihne SR; Buda F; Leurs R; de Groot HJ; DeGrip WJ
    J Am Chem Soc; 2007 Jan; 129(4):867-72. PubMed ID: 17243823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
    Filizola M; Weinstein H
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G-protein-coupled receptor affinity prediction based on the use of a profiling dataset: QSAR design, synthesis, and experimental validation.
    Rolland C; Gozalbes R; Nicolaï E; Paugam MF; Coussy L; Barbosa F; Horvath D; Revah F
    J Med Chem; 2005 Oct; 48(21):6563-74. PubMed ID: 16220973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation.
    Rubenstein LA; Zauhar RJ; Lanzara RG
    J Mol Graph Model; 2006 Dec; 25(4):396-409. PubMed ID: 16574446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural diversity of G protein-coupled receptors and significance for drug discovery.
    Lagerström MC; Schiöth HB
    Nat Rev Drug Discov; 2008 Apr; 7(4):339-57. PubMed ID: 18382464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Creation of GPCR-based chemical sensors by directed evolution in yeast.
    Ault AD; Broach JR
    Protein Eng Des Sel; 2006 Jan; 19(1):1-8. PubMed ID: 16263727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor.
    Tanrikulu Y; Proschak E; Werner T; Geppert T; Todoroff N; Klenner A; Kottke T; Sander K; Schneider E; Seifert R; Stark H; Clark T; Schneider G
    ChemMedChem; 2009 May; 4(5):820-7. PubMed ID: 19343764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.